Stephen J Rice

Search results

• 2024

  Disease Severity Modifier in the NICE Single Technology Appraisal of Trastuzumab Deruxtecan: External Assessment Group Perspective

  Coughlan, D., Arisa, O., Thomson, K., Yu, G., Pearson, F., Kernohan, A., Gonzalez-Moral, S. G., Wallace, S. & Rice, S., 1 Jan 2024, In: Pharmacoeconomics. 42, 1, p. 5-9 5 p.

  Research output: Contribution to journal › Comment/debate › peer-review